| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000009457 |
| Receipt No. | R000011112 |
| Scientific Title | Assessment of cardiac function using pressure-volume loops in congenital heart disease |
| Date of disclosure of the study information | 2013/01/01 |
| Last modified on | 2020/12/08 (Ver. 3) |
| Basic information | ||
| Public title | Assessment of cardiac function using pressure-volume loops in congenital heart disease | |
| Acronym | Assessment of cardiac function using pressure-volume loops in congenital heart disease | |
| Scientific Title | Assessment of cardiac function using pressure-volume loops in congenital heart disease | |
| Scientific Title:Acronym | Assessment of cardiac function using pressure-volume loops in congenital heart disease | |
| Region |
|
|
| Condition | |||
| Condition | Congenital heart disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To analyze detailed cardiac function in patients with congenital heart disease, especially with single ventricle physiology and systemic right ventricle. |
| Basic objectives2 | Others |
| Basic objectives -Others | To improve treatment strategy. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Systolic and diastolic cardiac function |
| Key secondary outcomes | blood pressure, ventricular pressure, cardiac output, circulatory blood volume, oxygen satulations. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Prevention | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Occlusion of the inferior vena cava, Dobutamine infusion, and atrial pacing. | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Those who are admitted to Tokyo Womens's Medical University Hospital, and undergo cardiac catheterization. Patients with single ventricle physiology, and systemic right and left ventricle. | |||
| Key exclusion criteria | 1. Patients with chromosomal disorders.
2. Patients with systemic syndrome. 3. Patients who may not tolerate occlusion of inferior vena cava. 4. Patients who are considered inadequate to undergo this study. |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokyo Women's Medical University | ||||||
| Division name | Department of Pediatric Cardiology | ||||||
| Zip code | 162-8666 | ||||||
| Address | 8-1 Kawada-cho Shinjuku-ku Tokyo | ||||||
| TEL | 0333538111 | ||||||
| ishido.mikiko@twmu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokyo Women's Medical University | ||||||
| Division name | Department of Pediatric Cardiology | ||||||
| Zip code | 162-8666 | ||||||
| Address | 8-1 Kawadacho SHinjukuku Tokyo Japan | ||||||
| TEL | 0333538111 | ||||||
| Homepage URL | |||||||
| ishido.mikiko@twmu.ac.jp | |||||||
| Sponsor | |
| Institute | Tokyo Women's Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tokyo Women's Medical University
Department of Pediatric Cardiology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo Women's Medical University |
| Address | 8-1 Kawada cho Shinjukuku Tokyo Japan |
| Tel | 0333538111 |
| ishido.mikiko@twmu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京女子医科大学病院 (東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011112 |